Argutus Medical
Dublin
About Argutus Medical
Argutus Medical is a world leader in developing and manufacturing specialised organ injury assays. Argutus Medical primarily focuses on developing ELISA tests and lateral flow rapid test devices for detection of acute kidney injury (Nephrotoxicity) and acute liver injury (Hepatotoxicity). Argutus also manufactures a range of other assays including OxyDNA, a unique test for oxidative DNA damage (Genotoxicity). Argutus Medical was previously part of Biotrin International before branching out in 2008. In 2010 Argutus Medical was acquired by EKF Diagnostics Holdings plc, a rapidly growing global health care company. Being part of EKF Diagnostics has allowed Argutus Medical to continue to focus on biomarker discovery and development of novel biomarker assays from their facility in Dublin, Ireland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: argutusmed.com
- Phone: +353-1-670-8576
Industries & Categories
Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/argutus-medical-1820498 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.